Submitted by Anonymous (not verified) on
Product Form
inject
API Generic 1
daratumumab
API Strength 1
20 mg/mL
Patent Expiration
Patent Number
  • US 7829673
  • US 9187565
  • US 9040050
Sub Title
DARZALEX